Hydroxyacetone - Manufacturers, Factory, Suppliers from China

Hydroxyacetone, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%
Read More

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...

2022.10.07 06:37:57
2022.10.06 04:10:29
2022.10.05 01:45:09
2022.09.14 22:44:35
2022.02.11 19:04:19
2022.01.06 18:45:02

Hydroxyacetone - Manufacturers, Factory, Suppliers from China

Related Products

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

4,6-Dichloronicotinic Acid CAS 73027-79-9 Purity >97.0% (HPLC) (T)

3,4-Dichlorophenylboronic Acid CAS 151169-75-4 Purity >99.5% (HPLC) Factory High Quality

Z-Gln-OMe CAS 2650-67-1 Purity >98.0% (HPLC)

N-Acetyl-DL-Alanine CAS 1115-69-1 Ac-DL-Ala-OH Assay 98.0~102.0% (Titration)

Boc-Glu(OBzl)-OH CAS 13574-13-5 Purity >98.0% (HPLC) Factory

2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7 Purity >99.0% (HPLC)

5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6 Rivaroxaban Intermediate Purity ≥99.0% (HPLC) Factory

4-Amino-3-Chlorophenol CAS 17609-80-2 Lenvatinib Mesylate Intermediate Purity >99.0% (HPLC)

1-Naphthylamine CAS 134-32-7 Purity >99.0% (HPLC)

4-Bromophenylacetic Acid CAS 1878-68-8 Purity >99.0% (GC) Factory High Quality

Trifluoroacetic Acid (TFA) CAS 76-05-1 Purity >99.5% (Titration) Factory

Fmoc-D-Tyr(tBu)-OH CAS 118488-18-9 Purity >99.0% (HPLC) Factory

The “Summit on COVID-19 Diagnostics & Treatment”

Yellow phosphorus and phosphoric acid rose together

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Method Of Analyzing Palladium Content In Palladium Catalysts

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

2022.10.07 06:37:57

2022.10.06 04:10:29

2022.10.05 01:45:09

2022.09.14 22:44:35

2022.02.11 19:04:19

2022.01.06 18:45:02

related search